Ketamine infusion therapy could offer hope for chronic pain patients

Millions of Americans live with chronic pain, a pervasive and often hidden epidemic. Research published in the Journal of Primary Care & Community Health underscores this reality, highlighting the toll aching, burning, shooting, or throbbing pain takes on individuals battling conditions like back pain, arthritis, and debilitating migraines. For those who find traditional pain management ineffective, a new avenue of hope is emerging: ketamine infusion therapy. While not without its challenges and limitations, this treatment offers a potential lifeline to those struggling to find relief, and Alpharetta residents facing chronic pain should be aware of this developing option.

The Challenge of Chronic Pain

Chronic pain, as defined by the Journal of Primary Care & Community Health, is often described as aching, burning, shooting, or throbbing—a constant and debilitating presence in the lives of millions. For Elanor Koch of Nebraska, this reality was profoundly personal. In 2020, doctors discovered a tumor on her cervical spine that had eroded and compressed her spinal cord by more than 60%, leading to significant pain and requiring neck fusion surgery and subsequent rehabilitation. Despite these interventions, Ms. Koch continued to experience debilitating pain that impacted her daily life. “Before, I would wake up in pain and live life in pain,” she explained. “I’d only have so much in me I could give a day until I would push myself into a flare that would leave me in bed for a handful of days.”

Ms. Koch initially explored opioid pain therapy, but deemed it an unsustainable long-term solution. She also found other alternative pain management approaches ineffective. Finding relief became a desperate search, as she struggled to “get a hold of or a grasp on how to manage my pain in a way that felt safe or effective.”

Ketamine Infusion Therapy: A Potential Solution

Seeking relief, Ms. Koch turned to ketamine infusion therapy in 2023 at Mind and Body Wellness Center. The treatment works by slowing down pain-sensing nerves that send messages to the brain, offering a novel approach to pain management. “When I’ve gone through ketamine, I had a perspective that I’d never been able to force myself into,” Ms. Koch said. “To see it for what it is and understand that that’s part of the experience of why we’re here and it didn’t feel like my pain was as daunting.” During the hour-long sessions, patients experience dissociation, a temporary detachment from their physical body, which allows for a different processing of thoughts and emotions. “You’re not fully aware of your physical body and you’re kind of just hanging out in your head for a while,” she described.

Following six treatments within a month, Ms. Koch reported experiencing a period of three months with minimal pain. While she now requires maintenance infusions about every few months, the therapy has significantly improved her quality of life. The cost of these infusions, ranging from $400 to $500 per session, presents a significant barrier to access, as they are generally not covered by insurance.

Esketamine: An Alternative Option

Recognizing the limitations of ketamine infusion therapy, Dr. Stephen Salzbrenner at Nebraska Medicine offers an alternative treatment: esketamine, a nasal spray chemically related to ketamine but with a distinct molecular structure and FDA approval for treating depression. “It’s pretty widely accepted in the scientific community that it’s effective and so it’s offered,” Dr. Salzbrenner said. “Now it’s not often covered by insurance ‘cause it’s not approved. If it was FDA-approved for depression, then insurance might cover it as a treatment.” Esketamine can provide relief within hours, a stark contrast to the weeks often required for traditional antidepressants to take effect. Dr. Salzbrenner emphasizes the crucial role of talk therapy alongside any medication regimen, stating, “Therapy is really indispensable…You can’t replicate that with a medicine.”

The Importance of Integrated Care

Ms. Koch reinforces the importance of a holistic approach, stating that she combines ketamine infusions with ongoing therapy and has discontinued antidepressant medications. “I have a psychiatrist and a talk therapist,” she said. “If my word counts for anything as somebody who could barely get out of bed two years ago, I’d say try it.” This highlights the critical need to address both the physical and mental aspects of chronic pain, recognizing that emotional well-being is deeply intertwined with physical suffering. The combination of medication and therapy can provide a more comprehensive and sustainable path to relief.

Potential Risks and Limitations

While ketamine infusion therapy offers hope, it’s crucial to acknowledge that it is not suitable for everyone. Individuals with certain medical histories, including schizophrenia, uncontrolled high blood pressure, heart disease, kidney or liver disease, and substance use disorder, may be unsuitable candidates. This underscores the importance of a thorough medical evaluation before considering ketamine infusion therapy. The potential benefits must always be weighed against the risks, and patients should engage in open and honest conversations with their healthcare providers.

Community Resources and Advocacy

For Alpharetta residents struggling with chronic pain, the availability of ketamine infusion therapy represents a potential new option to explore with their healthcare providers. However, the high cost of treatment—$400 to $500 per session—poses a significant obstacle for many families. This highlights the need for continued advocacy for affordable healthcare options and increased insurance coverage for innovative therapies. Residents seeking more information can explore resources such as the City of Alpharetta website for local health and wellness initiatives, the Fulton County Department of Health and Wellness for chronic disease management information, and the National Center for Complementary and Integrative Health (NCCIH) for information on alternative therapies.

Looking Ahead

The future of ketamine infusion therapy for chronic pain remains uncertain. While early results are promising, more research is needed to fully understand its long-term efficacy and safety. The lack of insurance coverage continues to be a major barrier to access, and advocacy efforts are needed to address this issue. Furthermore, ongoing collaboration between medical professionals, therapists, and patients is essential to optimize treatment outcomes and ensure responsible implementation of this therapy. The American Chronic Pain Association (acpa-pain.org) and the National Institute of Neurological Disorders and Stroke (ninds.nih.gov) offer valuable resources for those seeking information on chronic pain management.

Closing paragraph: The journey to finding effective pain relief is often long and arduous, but the emergence of treatments like ketamine infusion therapy offers a glimmer of hope for those who have exhausted other options. While challenges remain, the potential to alleviate suffering and restore quality of life is a worthy pursuit, and one that deserves continued attention and support within our community. It is a reminder of the importance of perseverance, compassion, and the unwavering pursuit of solutions to improve the well-being of our neighbors.